Trial intelligence / Profile preview

Remimazolam benzenesulfonate vs propofol for fiberoptic bronchoscopy sedation

ChiCTR2100045492Phase 4Recruiting

Sponsor
The First Affiliated Hospital of Zhengzhou University
Start
Apr 2021
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of remimazolam in anxiety disorder (2 arms), sponsored by The First Affiliated Hospital of Zhengzhou University. Primary endpoints: Systolic blood pressure, Diastolic blood pressure and 1 more. Started Apr 2021; status: recruiting.

02

Drugs

remimazolam
03

Conditions

anxiety disorder

Beyond the preview

Go deeper on ChiCTR2100045492.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2100045492.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call